Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Urgent need for disease-modifying drugs to arrest Parkinson’s disease progression: GlobalData
If any disease-modifying therapy managed to enter the PD market, it would revolutionise the treatment paradigm and generate a…
SII is legally bound to supply COVID-19 vaccines: COVAX
The pact specified Gavi would receive from SII 1.1 billion doses of either the AstraZeneca vaccine or that of Novavax, with 200…
J&J in discussions with Indian regulator to begin trial of single-dose vaccine
India has indicated that any vaccine maker must conduct such a trial for a shot to be considered for its immunisation programme
SII repays South Africa for COVID-19 vaccines that were not delivered
A million doses that had already been delivered, have been sold on to other countries in the African Union
Remdesivir’s price must not be more than Rs 1400 per vial: Maha Health Minister
Tope said with a rapid rise in COVID-19 cases, the state may need 1.5 lakh Remdesivir injections daily which would require ramping…
India to assess side effects of COVID-19 vaccine
India is currently administering AstraZeneca's COVID-19 vaccine and a shot developed at home by Bharat Biotech
OTC Drugs and E-Pharmacies: High time for regulation?
Renuka Abraham, Senior Associate and Priya Venkatesan, Associate with Spice Route Legal’s corporate practice group explain that…
Hester signs deal with ICAR – IVRI for Classical Swine Fever Vaccine and Sheep Pox Vaccine
As per the agreement, Hester will acquire the technologies for the production and commercialisation of the following vaccines from…
COVAX has delivered vaccines to over 100 countries, despite supply hits: GAVI/WHO
COVAX expects to deliver at least two billion doses of vaccines in 2021, informed a statement
Ramp up remdesivir manufacturing to full capacity: Govt to pharma firms
Mansukh Mandaviya said seven manufacturers - Mylan, Hetero, Jubiliant Life Sciences, Cipla, Dr Reddy's, Zydus Cadila and Sun…